DEPOMED INC's ticker is and the CUSIP is 24990810. A total of 3 filers reported holding DEPOMED INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $37,030,000 | -33.0% | 2,437,834 | -38.7% | 1.99% | -26.7% |
| Q2 2014 | $55,283,000 | -5.2% | 3,977,234 | -1.1% | 2.72% | -13.1% |
| Q1 2014 | $58,322,000 | +23.7% | 4,022,234 | -9.8% | 3.13% | +20.3% |
| Q4 2013 | $47,164,000 | +36.9% | 4,457,850 | -3.4% | 2.60% | +26.2% |
| Q3 2013 | $34,457,000 | +33.2% | 4,612,850 | +0.2% | 2.06% | +25.1% |
| Q2 2013 | $25,859,000 | – | 4,601,350 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 4,022,234 | $58,322,000 | 3.13% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 186,355 | $2,702,000 | 0.02% |
| SpiderRock Trading LLC | 300 | $1,000 | 0.01% |